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Abstract 
   Kinetic studies on the stability of the pain killer agent, paracetamol and its metabolite-
aminophenol and N-substituted benzamide derivatives in Al-Quds activated sludge demonstrated 
that paracetamol underwent a complete biodegradation within less than one month to provide 
hydroquinone via the intermediacy of p-aminophenol. Moreover, the results revealed that p-
aminophenol and benzamide underwent complete biodegradation within less than one week to 
furnish hydroquinone and benzoic acid, respectively. The pseudo first order reaction rate 
constants for those processes were found to be 2.17×10
-9
 M.s
-1
, 8.64×10
-9
 M.s
-1
 and 7.86×10
-9
 
M.s
-1
, respectively. Moreover, it was found that Pseudomonas aeruginosais the bacteria 
responsible for the biodegradation of the above mentioned amide pharmaceuticals. The 
efficiency of Al-Quds University wastewater treatment plant (AQU-WWTP) demonstrated that 
the ultrafiltration- hollow fiber unit (UF-HF) was insufficient in removing the studied amide 
pharmaceuticals (40% removal) and their metabolites from spiked secondary treated wastewater 
samples, whereas the ultrafiltration-spiral wound unit (UF-SW) (80% removal) followed by 
activated carbon column were quite efficient and yielded a complete removal of the 
pharmaceuticals (100% removal). Batch adsorption results of the amide containing 
pharmaceuticals: N-substituted benzamide derivatives, paracetamol and p-aminophenol onto 
activated carbon and octadecyltrimethylammonium) (ODTMA) – micelles clay complex were 
found to fit Langmuir and Freundlich Isotherms. In addition, the results demonstrated that the 
adsorption of these pharmaceuticals onto ODTMA micelles-clay complex was more efficient 
than activated carbon.  
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Chapter One 
Introduction 
 
1.1 Background: 
 
Water is a basis component for an environmental function. As the world population 
continues to increase, world seeks to secure supplies to meet the human needs of water, and 
greater dare arising in purifying water of poorer quality for reuse (Zimmo 2005).  
 
The water sources in Palestine are very limited. Groundwater is the main source of 
fresh water in Palestine, where the aquifer system is distributed to three main ground water 
drainage basins: the first in the western part of the West Bank, and the second in the 
northeastern part of the West Bank, while the third is in the eastern part of the West Bank. It 
mostly, lies under Israeli control. The second part of the water sources in Palestine is the 
surface water of the Jordan River (Zahra et al., 2001. Nazer et al.,  2008). 
 
The land in Palestine is semi-arid, where 70% of the available water is used in 
agriculture and about 27% is used in the domestic sector, while the remainder is used in 
industry (Zimmo 2005). Due to the water shortage, wastewater treatment technology 
(WWTT) has been utilized in Palestine to protect environmental pollution (such as ground 
water), and reuse the treated wastewater in agriculture (Bdour et al., 2009). 
 
Palestine as a one of the Middle East countries, less tribute to different factors as 
increasing population growth rate and industrializing, the increasing life style in water 
consumption, the wastewater treatment (WWT) is the best alternative to decrease the gap 
between supply and demand.  
 
Wastewater treatment (WWT) plants in Palestine include conventional such as 
activated sludge, bio-filters and others slightly less conventional, such as oxidation ditches, 
aerated lagoons and natural treatment system such as waste stabilization ponds (Al-Tamimi et 
al., 2008. Mcneill et al., 2009. Bdour et al., 2009). 
 
 
3 
 
The wastewater as a definition is a combination of water, 99% by weight, and solid 
material, about 1% by weight (dissolved material and suspended material). Wastewater 
contains organic materials, inorganic materials and microorganisms, where these components 
vary according to sources (EPA 1997). The wastewater sources can be divided into two types. 
First, domestic wastewater (DWW), or “sewage” and this type coms from homes, commercial 
places, and farms. DWW can also be divided into two types: black water which originates 
from toilets and kitchens and is highly contaminated and grey water which originates from 
baths, showers, wash basins and washing machine and is generally less contaminated. Grey 
water makes up 40% - 60% of the total DWW volume. The second type of wastewater 
isindustrial wastewater which is generated and discharged from manufacturing and 
commercial activities (EPA 1997, Metcalf 2003). 
 
The wastewater is classified according to physical, chemical and biological 
components. (1) The physical which includes total solid contents is subdivided into total 
suspended solids (TSS) and total dissolved solids (TDS), particle size distribution (PSD), 
turbidity, temperature, electrical conductivity (EC), transmittance, density, color, and odor. 
(2) The chemical includes organic chemical (biochemical oxygen demand (BOD), chemical 
oxygen demand (COD), total organic carbon (TOC), and total oxygen demand (TOD). This 
type also includes inorganic chemicals: salinity, hardness, pH, acidity and alkalinity, as well 
as concentrations of cationic ions such as ionized metals such as iron and manganese, and 
anionic such as chlorides, sulfates, sulfites, nitrates, and phosphates. (3) The biological 
includes total coliforms (TC), fecal coliforms (FC), specific pathogens, and viruses 
(Emmerson 1998, EPA 1997, Scott 2004,Vigneswaran 2009). 
 
The wastewater treatment process included physical, chemical and biological process. 
These processes can be divided into four stages: preliminary, primary, secondary and tertiary 
treatment process (EPA 1997). The preliminary, primary and secondary are called 
conventional wastewater treatment, they included a physical process such as sieve (for 
screening the large object and rags) and biological process such as activated sludge (to break 
down and removal of organic material). Fourth stage of treatment is a tertiary process and 
called advanced treatment of conventional effluent. Where use a physical and chemical 
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process (such as ozonation, membrane filtration ...and adsorption), (EPA 1997, US.EPA 2004, 
Bielefeldt 2009,Okoh 2009,Acero 2010) 
 Activated sludge is the most widely used methodology for WWT. In this process, the 
microorganisms are kept in suspension forming a biological flock while aeration basin by 
mechanical mixers or diffused air is maintained. The load of microorganisms is preserved by 
a continuous return of the settled biological flocks. As organic carbon is the most important 
energy source, heterotrophic bacteria dominate in activated sludge systems. Several variations 
of the activated sludge process have been developed in order to optimize carbon, nitrogen, 
and phosphorous removal from the wastewater (Kämpfer et al., 1996).  
 
Communities of prokaryotic microorganisms present in activated sludge are 
responsible for all of the carbon and nutrient removal from sewage and thus represent the core 
component of the biological wastewater treatment plant (WWTP). Consequently, a thorough 
knowledge of the ecology of the microbial community is required to reveal factors influencing 
the efficiency and stability of biological WWTP and to develop promising strategies for 
improved process performance (Wagner 2002). Therefore, the microbiological details, 
including the compositions of the microbial populations that are responsible for the 
mineralization processes, are very important in increasing the treatment efficiency (Kämpfer 
et al., 1996). 
 
Microbial populations in WWTP are frequently analyzed either by light microscopic 
observation (Eikelboom 1975, Jenkins 1993) or by cultivation-dependent techniques (Ueda 
1972, Seiler 1982). These approaches lead to the postulation of model organisms for the most 
important microbiologically driven processes in WWTP (Henze 1997). During the past 
decade, a variety of approaches were also developed and used to study bacterial diversity in 
WWTP (Wagner 2002). Extensive studies using cultivable microorganisms that require their 
isolation and identification were performed. Characterization of bacterial populations in the 
environment samples including raw wastewater using commercially available identification 
kits was previously documented (Kämpfer et al., 1989. Kämpfer et al., 1990. Kämpfer et al., 
1996). 
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Several pharmaceutical compounds and their metabolites have been detected in 
wastewater as well as in surface and drinking water; they were found at concentrations up to 
µg/L level in influent and effluent samples from WWT and also in surface water. Polar 
pharmaceutical compounds leach through the subsoil to ground water and have been detected 
up to the µg/L level (Egun 2010, Yu 2006). 
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1.2 Selected pharmaceutical containing amide bonds 
 
1.2.1 Paracetamol 
Paracetamol (Figure 1.2-a) is available in different dosage forms such as tablets, 
capsules, drops, elixirs, suspensions and suppositories. Its saturated aqueous solution has a pH 
of about 6 and is stable with a half-life exceeding 20 years, but its stability decreases in acidic 
or alkaline conditions due to being slowly degraded, via a base or acid hydrolysis of the amide 
bond, into acetic acid and p-aminophenol (Figure 1.2-b). Paracetamol is metabolized 
primarily in the liver, into non-toxic products via three metabolic pathways (Figure 1.1). 
Glucoronidation is believed to account for 40-66% of the metabolism of paracetamol; and 
sulfation (sulfate conjugation) may account for 20-40% (Nelson 2006).N-hydroxylation and 
rearrangement, then GSH conjugation, account for less than 15%. The hepatic cytochrome 
P450 enzyme system metabolizes paracetamol, forming a minor yet significant alkylating 
metabolite known as NAPQI (N-acetyl-p-benzoquinone imine). NAPQI is then irreversibly 
conjugated with the sulfhydryl groups of glutathione. All mentioned three pathways yield 
final products that are inactive, non-toxic, and eventually excreted by the kidney. In the third 
pathway, however, the intermediate product NAPQI is toxic. NAPQI is primarily responsible 
for the toxic effects of paracetamol (Williams 2002). 
 
 
Figure 1.1 Main pathways of paracetamol metabolism, Pathways shown in blue and purple 
lead to non-toxic metabolites; the pathway in red leads to toxic NAPQI. 
 
 
7 
 
1.2.2 Benzamide 
 
Benzamide (Figure 1.2-d) and N- substituted derivatives of benzamide are reported to 
possess antiemetic, antipsychotic and antiarrhythmic activities (Clark 1985, Vamecq 1997). 
 
1.2.3 Bezafibrate 
 
Bezafibrate (Figure 1.2-c) is one of the most popular compounds of the fibrate 
hypolipidaemic class of drugs. Its pharmacological activity consists in reducing serum 
triglyceride (22%) and low density lipoprotein cholesterol (LDL-C) (5%) levels and 
significantly raising high density lipoprotein cholesterol (HDL-C) fraction. It is widely used 
in the treatment of hypertriglyceridemia, which is now recognized as an independent risk 
factor of a coronary artery disease (CAD) (Duriez 1999). About 95% of orally administered 
bezafibrate is bounded by albumin and most of the absorbed drug is excreted in urine. It is 
known that approximately 50% of the administered dose is not completely metabolized and its 
unchanged form is excreted in urine within 24 hours (Abshagen 1979). 
 
1.2.4 Atenolol 
 
Atenolol (Figure 1.2-e) is available in different dosage forms such as tablets, oral 
solution and injection. It is beta-adrenergic antagonist. Atenolol is incompletely absorbed 
through the intestine (about 50%), but most of the absorbed dose reaches the systemic 
circulation. Peak blood levels are reached between two and four hours after ingestion. Unlike 
propranolol or metoprolol, atenolol undergoes little or no metabolism by the liver and the 
absorbed portion is eliminated by renal excretion. Over 85% of intravenous dose is excreted 
in urine within 24 hours compared with 50% for an oral dose. Only a small amount (6-16%) is 
protein-bound resulting in relatively consistent plasma drug levels with about a four-fold 
inter-patient variation. The elimination half-life of atenolol is 6 to 7 hours and there is no 
alteration of kinetic profile of drug by chronic administration. Following intravenous 
administration peak plasma levels are reached within 5 minutes. Declines from peak levels are 
rapid (5 to 10 fold) during the first 7 hours. Following oral doses of 50 mg or 100 mg both 
beta-blocking and anti-hypertensive effects persist for at least 24 hours (Wander et al., 2009).  
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Figure 1.2: Physiochemical properties of selected pharmaceuticals, (a) Paracetamol, (b) P-
aminophenol, (c) Bezafibrate, (d) Benzamide and (e) Atenolol. (B.P. 2009, Champman 1982). 
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1.3 Thesis Objectives 
 
The main objectives of my thesis were (1) to investigate the stability of amide 
pharmaceuticals in wastewater (activated sludge) and (2) to study their removal along with 
their metabolites by micelle-clay complex and advance membranes technology. 
The sub-goals of this thesis were to investigate: 
 
 The stability of the amide pharmaceuticals in fresh water and activated sludge and to 
conduct comparisons between both. 
 
 The biodegradation of the amide pharmaceutical by isolated bacteria (this bacterium 
was detected and isolated from AQU-WWTP sludge). 
 
 The efficiency of the Al-Quds University wastewater treatment plant (AQU-WWTP) 
towards removing the amide pharmaceuticals and their degradation products. 
 
 The removal of the amide pharmaceuticals and their degradation products using low 
cost adsorbent materials (micelle-clay complex and activated carbon). 
 
1.4 Thesis Outline  
 
This thesis consists of five chapters: the first chapter which includes the introduction 
and selected amide pharmaceuticals and their chemical and physical properties, the second 
chapter which includes literature review on the occurrence of pharmaceuticals in wastewater 
and fresh water and the removal methods and biodegradation of amide pharmaceuticals. The 
third chapter includes the materials, instrumentation and methods used in sampling, sample 
treatment and analysis. The fourth chapter includes the results and discussion of the stability 
of the amide pharmaceuticals and their removal along with their degradation products using 
advances membranes technology, clay micelles complex and activated carbon. The fifth 
chapter includes the conclusion and recommendation and the final chapter lists references. 
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Chapter Two 
Literature Review 
 
2.1 Introduction. 
 
2.1.1 Occurrence of pharmaceuticals in the environment. 
 
 The occurrence and fate of pharmaceuticals residues in wastewater and the 
environment have attracted an increasing interest during the last decade (Halling-Sorensen et 
al., 1998, Lorphensri et al., 2007, Ternes et al., 1998). Many organic compounds, such as 
pharmaceuticals; enter the sewage through several sources such as industrial and household 
effluents. 
 
The removal of many of these pharmaceuticals during municipal WWT has been 
found to be incomplete (Ternes et al., 1998, Ashton et al., 2004, Carballa et al., 2004, Heberer 
et al., 2002, Quintana et al., 2004, Stumpf et al., 1996). When they enter a WWTP, some 
pharmaceuticals are either partially retained in the sludge or metabolized to more hydrophilic 
but still persistent forms and, therefore, pass through the WWTP and end up in the effluent 
(Radjenovic et al., 2007). As a result, residues of these compounds have been detected in 
surface water in concentrations ranging from ng/L up to mg/L level (Ternes et al., 1998, 
Ashton et al., 2004, Carballa et al., 2004, Buser et al., 1999, Tixier et al., 2003). 
Occurrence of pharmaceuticals (such as paracetamol) and personal care products 
(PPCPs) in raw sewage samples collected from the Baltimore Back River WWTP (Yu et al., 
2006). Reported the 9 of PPCPs in marine sediments, Brazil, at range from 52.5 ng/g to 0.71 
ng/g (Beretta et al., 2014).The concentration of PPCPs range 19 ng/g – 2100 ng/g was fund in 
fish samples collected from different river at United States (Ramirez et al., 2009).  
  
The reported removals of paracetamol in WWTP are varying from almost complete to 
86% in municipal and 80% in hospital WWTP (Gomez et al., 2007, Jones et al., 2007, 
Radjenovic et al., 2009, Rosal et al., 2010, Sim et al., 2010, Stackelberg et al., 2004). Yet, the 
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removal is not complete since concentrations ranging from several hundred nano-grams up to 
11.3 mg/L have been found in European WWTP effluents (Ternes et al., 1998, Jones et al., 
2007, Rabiet et al., 2006). Other researchers found that paracetamol has been found with at 
concentrations of up to 6 mg/Lin European sewage treatment plants (STP) effluents, and up to 
10 µg/L in natural water in USA (Kolpin et al., 2002, Sim et al., 2010), and even more than 65 
µg/Lin the Tyne River in the UK, 10μg/L in surface water in the US (Kolpin et al., 2002). 
Rabiet et al. (2006) have detected a value of 211 ng/L of paracetamol in drinking water in 
France.  
 
Bezafibrate has been found at concentrations up to 500 ng/L, 200 ng/L and 20 ng/L in 
influent, effluent and Ebro River in Spain, respectively (Gros et al., 2010).And record detected 
in concentration ranged 200 – 1600 ng/L level influent WWTP (Jelic et al., 2012). Atenolol 
has been frequently identified in wastewaters, where atenolol was detected in the highest 
concentrations, in some cases ranging up to 1 mg/L (Jelic et al., 2012). 
 
2.1.2 Removal of pharmaceutical compounds and their metabolites 
 
Even that pharmaceuticals residue and their metabolites are usually detectable in the 
environment at trace levels, the low concentration level (ngL
-1
 - µgL
-1
) can induce toxic effects, 
as in the cases of antibiotic and steroids that cause resistance in natural bacterial populations or 
endocrine disruption effects (Herando et al., 2005). Pharmaceutical compounds are designed to 
interact with receptors in humans and animals, but in aquatic environment the organisms 
exhibiting the same enzyme receptors as humans could experience similar pharmacodynamic 
effects. Another issue at the ecosystem level is that for continual exposure of organisms due to 
continuous discharge of sewage contaminants into receiving waters (Comeau et al., 2008). 
Although concentrations of many pharmaceuticals residues in potable drinking water are so low 
and do not pose high risks to human beings, the main concern is the chronic and/or synergistic 
effects of the “cocktail” of pharmaceuticals that human have released to water body (Webb et al., 
2003, Nikolaou et al., 2007). 
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The methods of treatment used for the removal of pharmaceuticals from the wastewater are 
the following: (a) biodegradation, (b) de-conjugation, (c) partitioning, (d) removal during sludge 
treatment, (e) photo-degradation, (f) membrane technology, (g) adsorbent materials (Jones et al., 
2005). 
 
(a) Biodegradation: biological degradation can take place in wastewater by means of 
aerobic/anaerobic microbial degradation of the drug substance leading to reduction of parent 
compounds and/or their metabolites during wastewater treatment (Jones et al., 2005). The 
microbes include bacteria, yeasts, fungi, protozoa, as well as unicellular plants and rotifers, some 
of these organisms have the ability to degrade some of most hazards and recalcitrant chemicals 
(Maria et al., 2010). 
 
(b)  De-conjugation: pharmaceuticals compounds are often metabolized in the liver, and as a 
consequence gluconoride and sulfate conjugates of the parent drug are excreted, de-conjugation 
in domestic wastewater and within sewage treatment plans (STPs), for organic compounds such 
as steroid hormones were occur due to the large amounts of β-glucoridase enzyme present, 
gluconoride and sulfate conjugates of drug compounds will be degraded by the same process, the 
effect will be increase the excreted contribution of the active drugs to sewage and effluents 
(Adriano et al., 2005). 
 
(c) Partitioning: partitioning between the aqueous and organic biomass phase consider the key 
component in determining the ultimate concentration of organic pollutants. Compounds with 
high log Ko/w (lipophilic molecules) values are known to sorb to sludge, while substances with 
lower values are more likely to stay in the aquatic phase, depending on the individual compound, 
and substances sorbing to solids may also be remobilized if they are not strongly bound (Jones et 
al., 2005). 
 
(d) Removal during sludge treatment: drugs may also be degraded by a biotic process 
(Hydrolysis) during sewage treatment process. Many pharmaceutical compounds are not 
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thermally stable, and so might be expected to break down during processes such as compositing 
due to heat as well as chemical and biodegradation (Jones et al., 2005). 
 
Removal of pharmaceutical from wastewater using microbiological processes, such as 
membrane bioreactor (MBR) technology was studied, the combination of DAF (dissolved air 
flotation) MBR-ozone oxidation process get a removal percentage range 50-95 % for the 
removal of some pharmaceutical such as bezafibrate (Miyoung et al., 2012). While only 10 % 
removal of neutral carbamazepine or basic atenolol, metoprolol and trimethoprim by activated 
sludge (Paxéus et al., 2004). 
 
(e) Photo-degradation: several pharmaceutical compounds have shown to degrade due to the 
action of sunlight, some pharmaceuticals compounds such as diclofenac which is analgesic/anti-
inflammatory drug, has been shown to degrade in aquatic environment due to ultraviolet (UV) 
light (Jones et al., 2005). 
 
Due to an incomplete elimination in wastewater treatment plants (WWTPs) using the 
conventional treatment method, residues of pharmaceuticals and PPCPs are found in both 
wastewater and surface water (Adriano et al., 2005), so the improvement of this situation require 
the application of advanced treatment techniques, such as membrane filtration technology, many 
studies reported as significant efficiency of nano-filtration and reverse osmosis (Zhou et al., 
2002), advanced oxidation processes (Ikehata et al., 2006), and activated carbon adsorption 
(Jones et al., 2005, Zhou et al., 2002). 
 
Advanced oxidation processes (AOPs) constitute a promising technology for the 
treatment of wastewaters containing PPCPs. Data concerning the degradation of PPCPs by 
means of AOPs reported during the period January 2000–May 2007 are evaluated in a review 
article (Santiagoet al., 2007). Photo-catalytic degradation of sulfamethoxazole in aqueous 
suspension an 82% of sulfamethoxazole degradation and 23% of TOC reduction was achieved 
when working with 0.5 g TiO2/L (Abellán et al., 2007). Paracetamol removal by photo-
degradation using ozonation and H2O2/UV system was complete within 1 min in aqueous 
mixture at pH 5 (Andreozzi et al., 2003).  
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(f) Membrane technology has been applied in various fields of wastewater treatment. 
Micro-filtration (MF), Ultra-filtration (UF) and Nano-filtration (NF) membrane systems have 
already proven their advantages in terms of removal efficiency. Reverse osmosis (RO) and 
Activated carbon (AC) are also used in a broad range of wastewater reuse. Ultrafiltration 
hollow fiber membrane was less efficient to removal of naproxen, diclofenac and heavy metal 
Cr (VI), the RO and AC membranes were found to be complete removal (100%) of this 
pollutant (Karaman et al., 2012, Qurie et al., 2013). Aspirin, paracetamol and their metabolite 
salicylic acid and p-aminophenol were complete removal while pass through UF, RO and AC 
membranes (Khamis et al., 2011). 
 
The wastewater treatment plant included activated sludge, UF, AC and RO, the result of 
overall plant membrane system showed complete removal of amoxicillin trihydrate and 
cefuroxime axetil (Karaman et al., 2015). 
 
(g) Adsorbent materials: adsorption is considered to be one of the most promising 
techniques for wastewater treatment over the last decades.   Under this term “green 
adsorption” it is meant the low-cost materials originated from:  Agricultural sources and by-
products (fruits, vegetables, foods). Agricultural residues and Wastes. Low-cost sources from 
which most complex adsorbents will be produced (such as activated carbons). These “green 
adsorbents” are expected to be inferior to the super-adsorbents complex materials as modified 
chitosans, activated carbons, structurally-complex inorganic composite materials etc., but 
their cost-potential makes them competitive (Kyzas et al., 2014).Freundlich isotherm constant 
for COD adsorption using three different types of activated carbon was range from 66.10 L/g 
to 146.30 L/g of K constant and 0.59 to 0.72 for 1/n constant (Amuda et al., 2006). The result 
for removal of Cr (VI) from aqueous solutions using either clay or modified clay (micelle-
clay complex), indicate that modified clay (86%) was more efficient than used clay (50%) 
(Qurie et al.,2013). 
 
Through continuous research, adsorption studies using two low cost adsorbents, 
activated carbon and positively ODTMA-complex (micelle-clay complex), revealed that both 
adsorbents are efficient in removing the pharmaceutical together with their biodegradation 
products, pesticide and toxic heavy metal Cr (VI). The adsorption isotherms were found to fit 
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Langmuir isotherms and the adsorption parameters were evaluated (Khamis et al., 2011, 
Karaman et al., 2012, Qurie et al., 2013, Karaman et al., 2015). 
 
This thesis reports the efficiency of these advanced technologies for removal of selected 
pharmaceuticals, paracetamol, p-aminophenol, benzamide, bezafibrate and atenolol at the 
wastewater treatment plant at Al-Quds University which includes ultrafiltration (hollow fiber and 
spiral wound). 
 
This study reports the removal of these selected pharmaceuticals (paracetamol, p-
aminophenol, benzamide, bezafibrate and atenolol) by ultrafiltration (hollow fiber and spiral 
wound), their adsorption by activated carbon and clay-micelle filters, and removal by reverse 
osmosis technology. 
 
2.1.3 Biodegradation of pharmaceutical compounds 
 
Biodegradation of pharmaceutical compounds was studied (Zwiener et al., 2002, 
Gusseme et al., 2011, Zhang et al., 2012). This process considered the most important process 
for the removal of pharmaceuticals from activated sludge during the WWT. While 
transformation of pharmaceuticals in humans mammals has been studied extensively, the 
microbial degradation of pharmaceuticals in activated sludge, their degradation pathways and 
products, has rarely been investigated and their pathways are largely unknown (Quintana  et 
al., 2005). 
 
Biodegradation of pharmaceuticals was studded by batch incubation experiment using 
activated sludge as microbial (Yu et al., 2006), or isolated bacteria (Gusseme et al., 
2011).Paracetamol with initial concentration 50, 10 and 1 mg/L of, was incubated at 25 
o
C, 
and the result showed fast biodegradation rate of paracetamol and complete biodegradation 
following 14 days of incubation. Biodegradation results were not sensitive to the initial 
concentration (Yu et al., 2006).paracetamol was underwent hydrolysis to p-aminophenol by 
batch incubation experiment using activated sludge (Schröder et al., 2012). In batch 
incubation experiment using isolated bacteria (Delftia-Tsuruhatensis and Pseudomonas 
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Aeruginosa) of 10 mg paracetamol at 28 
o
C in minimal medium, amide cleavage to produce 
p-aminophenol as intermediate to produce hydroquinone (Gusseme et al., 2011). 
 
On the other hand, N, N-Diethyl-3-Methylbenzamide (DEET), derivative of benzamide 
was degraded into 3-methylbenzoate and diethylamide by amide hydrolysis through 
incubation with Pseudomonas putida in aerobically condition (Rivera et al., 2007). 
The biodegradation of bezafibrate were studied by using activated sludge (from membrane 
bioreactor), with 20 mg as initial concentration, the results showed that bezafibrate was 
degraded to one metabolite within 5 days: the metabolite was identified as 4-chlorobenzoic 
acid (Quintana et al., 2005). Biodegradation of bezafibrate in activated sludge, the result 
showed a hydrolysis of amide bond, two products were identified as 4-chlorobenzoic acid and 
4-(2-aminoethyl)-α, α-dimethyl-benzene acetic acid (Gusseme et al., 2011). Degradation of 
bezafibrate using isolated bacteria (pseudomonas putida): a 48% of bezafibrate was 
underwent biodegradation within 5 days (Yang et al., 2010). 
 
Biodegradation of atenolol under aerobic condition in activated sludge with initial 
concentration 50 mg/L and 10mg/L, the produce was determined to be a microbial hydrolysis 
of the amide bond (Radjenovi et al., 2008). 
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Chapter Three 
Experimental 
 
3.1 Chemicals  
 
All chemicals were of analytical grade. The clay used was Wyoming Na-
montmorillonite SWY-2 obtained from the Source Clays Registry (Clay Mineral Society, 
Colombia, MO). Octadecyltrimethylammonium (ODTMA) bromide was obtained from 
Sigma Aldrich.  Paracetamol was obtained as a gift from Bir-ziet pharmaceutical company 
(Ramallah-Palestine). Bezafibrate was extracted from Bezafibrate 400mg Tablets. Activated 
Charcoal (12-20 mesh) was obtained from Sigma (Sigma Chemical Company, USA). De-
ionized water was used to prepare all solutions.  Methanol, acetonitrile and water were HPLC 
grade and purchased from Sigma Aldrich. Magnesium sulfate, benzamide, ammonium 
acetate, acetic acid, atenolol, benzoic acid and p-aminophenol were purchased from Sigma 
Aldrich.  Chloroform and High purity diethyl ether (> 99%) were purchased from Biolab 
(Israel), orthophosphoric acid (OPA) was obtained from Riedel-De Haen (Germany). Syringe 
Millipore filter 13 mm diameter 0.45µm Nylon membrane and peptone water were obtained 
from sigma Aldrich. 
 
3.2 Instrumentation 
 
3.2.1 High Pressure Liquid Chromatography 
 
High Pressure Liquid Chromatography (HPLC-PDA) system consists of an alliance 
2695 HPLC from (Waters), and waters Micromass® Masslynx ™ detector with Photo diode 
array (PDA) (Waters 2996). Data acquisition and control were carried out using Empower™ 
software (Waters). Analytes were separated on a 4.6 mm x150 mm C18 XBridge ®column (5 
μm particle size) used in conjunction with a 4.6mmx20 μm XBridge ™ C18guard column. 
Microfilter was used with 0.45μm (Acrodisc® GHP, Waters). 
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3.2.2 UV-Spectrophotometer 
 
The concentrations of the amide pharmaceuticals in wastewater samples were 
determined spectrophotometrically (UV-spectrophotometer, Model: UV-1601, Shimadzu, 
Japan) by monitoring the absorbance at the λmax for each pharmaceutical. 
 
3.2.3 pH meter 
 
pH values were recorded using pH meter (model HM-30G: TOA electronics ™). 
 
3.2.4 Centrifuge and Shaker 
 
Labofuge®200 Centrifuge was used (230 V 50/60 Hz. CAT. No. 284811, made in 
Germany). Some of pharmaceuticals solutions were shaken with an electronic shaker (Bigbill 
shaker, Model No.: M49120-26, 220-240 V 50\60 Hz.) at 250 rpm. 
 
 
3.2.5 Description of Al-Quds University Wastewater Treatment Plant (AQU-WWTP) 
 
The AQU-WWTP collects a mixture of black, gray, and storm water. The treatment 
plant consists of a primary treatment (two stage primary settling basin), and a secondary 
treatment (activated sludge with a hydraulic retention time of 16-20 hours, coagulation and 
chlorination). Then, the secondary effluents introduced to the sand filter before entering the 
ultra-filtration membrane (Hollow fiber and Spiral wound). After the ultra-filtration process, 
the effluent is subjected to activated carbon column followed by a reverse osmosis (advanced 
treatment). Then, a blend of all effluents is used for irrigation. The ultra-filtration process is 
made of two small scale membrane treatment plants with a capacity of 12 m
3
 /day. The first 
UF unit is equipped with 2 x 4 inch pressure vessels with pressure resistance up to 150 psi. 
Each vessel holds two separation membranes (spiral wound with 20 kD cutoffs which is 
equivalent to 0.01micron separation rate). The designed permeate capacity of the system is 
0.5-0.8 m3/h. This Membrane can remove bacteria, suspended solids, turbidity agents, oil, and 
emulsions. The second unit is equipped with two pressure vessels made from Vendor (AST 
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technologies, model number 8000 WW 1000-2M) that houses the hollow fiber membranes 
with 100 kD cutoff (Vendor, AST technologies, Model no. 8000- WWOUT-IN-8080). The 
two units are designed to deliver 1 .5m3/h. The reverse osmosis (RO) membranes are made 
from thin film polyamide which consists of 1 x 4 inch pressure vessel made from composite 
material with pressure resistance up to 400 psi. The vessel holds two 4 inches special 
separation membranes (manufactured in thin film polyamide with pH range 1-11models 
BW30-4040 by DOW Film Tec.). Membrane antiscalent (Product NCS-106-FG, made of 
phosphate in water with active ingredient of phosphoric acid disodium salt) are continuously 
dosed to the RO feed at concentration of 4 ppm in order to prevent deposition of divalent ions. 
The system is designed to remove major ions and heavy metals. The designed RO permeate 
capacity of the system is 0.45- 0.5 m3/h (Khamis et al., 2011). 
 
3.3 Methods 
3.3.1 Micelle-clay complex preparation 
 
The micelle-clay complex was prepared as described elsewhere (Polubesova et al., 
2005). Briefly, the micelle–clay complex was prepared by stirring 12 mM of ODTMA with 
10g/ L clay for 72 h. Suspensions were centrifuged for 20 min at 15000 rpm, supernatants 
were discarded, and the complex was lyophilized. 
 
3.3.2 Stability of selected pharmaceutical 
 
3.3.2.1 Stability of paracetamol and p-aminophenol 
 
Stability studies were conducted either in fresh water, activated sludge or sterile 
peptone water containing Pseudomonas aeruginosa, by dissolved 100 mg of paracetamol 
standard or 100 mg of p-aminophenol standard in 1L.The solutions were incubated in water 
bath at a temperature of 25 
o
C for 14 days. 
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In another experiment, 100 mg, 250 mg and 500 mg of paracetamol standard was 
dissolved in sterile peptone water containing Pseudomonas aeruginosain the same condition 
to achieve the variation of paracetamol concentration effect on biodegradation rate constant. 
 
3.3.2.1.1 Sampling and sample preparation 
 
10 ml of paracetamol or p-aminophenol samples were taken every day of incubation; 
all samples were centrifugation and extracted three times with ether or chloroform. The ether 
or chloroform extracts were combined, dried on anhydrous magnesium sulfate (MgSO4), 
filtered and evaporated. For HPLC-PDA analysis, the dried residue after solvent evaporation 
was dissolved with a mixture of water: acetonitrile (water adjusted to pH 3.45 using dilute o-
phosphoric acid) in a ratio (90:10 v\v) and was injected to the HPLC apparatus. 
 
3.3.2.1.2 Stock solution and standards preparation 
A- Stock solution: Stock solution was prepared by dissolving paracetamol, or p-
aminophenol, standards in acetonitrile and water which was adjusted to pH 3.45 in a ratio 
(10:90) to a concentration 200 ppm. 
 
B- Calibration curves: A 500 ml stock solution of paracetamol or p-aminophenol, with 
a final concentration of 200 ppm was prepared in (A). The diluted solutions that were 
prepared from the stock solution were: 0.5 ppm, 1 ppm, 5 ppm, 10 ppm and 100 ppm. Then, 
each diluted solution was extracted three times with ether or chloroform. The ether or 
chloroform extracts were combined, dried on anhydrous magnesium sulfate (MgSO4), filtered 
and evaporated. For HPLC-PDA analysis, the dried residue after solvent evaporation was 
dissolved with a mixture of water: acetonitrile (water adjusted to pH 3.45 using dilute o-
phosphoric acid) in a ratio (90:10 v\v) and was injected to the HPLC apparatus. 
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3.3.2.1.3 Chromatographic conditions for the separation of paracetamol and p-
aminophenol  
 
The optimal HPLC conditions that were efficient for the separation of paracetamol and 
p-aminophenol were: C-18 as the separation column, a mixture of water: acetonitrile (water 
pH adjusted to 3.45 using dilute o-phosphoric acid) (90:10 v/v) as a mobile phase,  flow rate 
of 1.0 ml/ minute and a UV detection at a wavelength of 247 nm.  
3.3.2.2 Stability of benzamide 
 
Stability studies were conducted either in activated sludge, fresh water or sterile 
peptone water containing Pseudomonas aeruginosa, by dissolving 100 mg of benzamide in 
1Liter.The solution was incubated in water bath at a temperature of 25C
o 
for 14 days. 
 
3.3.2.2.1 Sampling and sample preparation 
 
10 ml of benzamide samples were taken every day of incubation; all samples were 
centrifugation and extracted three times with ether or chloroform. The ether or chloroform 
extracts were combined, dried on anhydrous magnesium sulfate (MgSO4), filtered and 
evaporated. For HPLC-PDA analysis, the dried residue after solvent evaporation was 
dissolved with a mixture of water: acetonitrile (water adjusted to pH 3.0 using dilute o-
phosphoric acid) in a ratio (70:30 v\v) and was injected to the HPLC apparatus.  
 
3.3.2.2.2 Stock solution and standards preparation 
 
A- Stock solution: Stock solution was prepared by dissolving benzamide standard in 
acetonitrile and water that was adjusted to pH 3.0 in a ratio (30:70) to a concentration 200 
ppm.   
 
B- Calibration curves: A 500 ml stock solution of benzamide with a final concentration 
of 200 ppm was prepared in (A). The diluted solutions that were prepared from the stock 
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solution were: 10 ppm, 50 ppm, 100 ppm and 200 ppm. Then, each diluted solution was 
extracted three times with ether or chloroform. The ether or chloroform extracts were 
combined, dried on anhydrous magnesium sulfate (MgSO4), filtered and evaporated. For 
HPLC-PDA analysis, the dried residue after solvent evaporation was dissolved with a mixture 
of water: acetonitrile (water adjusted to pH 3.0 using dilute o-phosphoric acid) in a ratio 
(70:30 v\v) and was injected to the HPLC apparatus. 
 
3.3.2.2.3 Chromatographic conditions for the separation of benzamide and metabolite 
 
The optimal HPLC conditions that were efficient for the separation of benzamide and 
metabolite were: C-18 as the separation column, a mixture of buffer: acetonitrile (Buffer 
solution: 0.4 g of ammonium acetate in 1L distilled water, pH adjusted to 4.2 using dilute o-
phosphoric acid, buffer solution was filtered through 0.45µm and storage at 4
o
C) (80:20 v/v) 
as a mobile phase, flow rate of 1.0 ml/ minute and a UV detection at a wavelength of 230 nm.  
 
3.3.3 Efficiency of the AQU-WWTP for removal of selected pharmaceuticals.  
 
The efficiency of different membranes (hollow fiber (HF-UF), spiral wound (SW-UF), 
activated carbon (AC) and reverse osmosis (RO) membranes, for the removal of selected 
pharmaceuticals from wastewater was studied by spiking the selected pharmaceuticals in the 
storage tank of the wastewater treatment plant at a concentration rang 30-45 ppm. 
 
3.3.3.1 Spiking solutions 
 
Dissolve 20 g of paracetamol and p-aminophenol, (separately), in 50 ml methanol and 
spike in 500 liters of activated sludge wastewater to a concentration of 40 ppm. Dissolve 17.5 
g of benzamide in 50 ml methanol and spike in 500 liters of activated sludge wastewater to a 
concentration of 35 ppm. Dissolve 15 g of bezafibrate and atenolol, (separately), in 50 ml 
methanol and spike in 500 liters of activated sludge wastewater to a concentration of 30 ppm. 
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3.3.3.2 Stock solutions and standard preparation 
A- Stock solution: Each stock solution of a selected pharmaceutical standard was 
prepared in a separated volumetric flask 100 ml by dissolving the compound in small amount 
methanol then distilled water to a concentration of 100 ppm.   
 
B- Calibration curves: Each 100 ml stock solutions of each compound with a final 
concentration of 100 ppm prepared in (A) was used to prepare the following diluted solutions: 
0.1 ppm, 0.5 ppm, 1 ppm, 5 ppm, 10 ppm, and 50 ppm. Then, the absorption of each solutions 
of each of the tested compounds was determined using UV-spectrophotometer. 
3.3.3.3 Sampling and sample preparation 
 
50 ml of samples were taken from the following points of the AQ-WWTP: (A) storage 
tank (before running wastewater treatment plant) (B) and (C) Brine and product of the UF/HF 
membrane, respectively, (D) and (E) Brine and product of the UF/SW membrane, 
respectively, (F) product of activated carbon, (G) and (H) Brine and product of the reverse 
osmosis membrane. These sampling points are shown in (Figure 3.1). Samples were treated 
by centrifugation and filtration through 0.45µm syringe Millipore nylon filter, then 
measurement the samples using UV-vis. 
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Figure 3.1: Flow diagram showing the process of AQU-WWTP which consists of UF/HF-
filter (Hollow Fiber Membrane) and UF/SW-filter (Spiral Wound Membrane), Activated 
Carbon and RO filters (Reverse Osmosis Membrane). Sampling locations are indicated by 
letters. 
3.3.4 Adsorption studies of selected pharmaceuticals onto micelle-clay complex and 
activated carbon. 
 
3.3.4.1 Stock solution and standards preparation 
 
A- Stock solution: each stock solution of a selected pharmaceutical standard was 
prepared in a separated volumetric flask 500 ml by dissolving the compound in distilled water 
to a concentration of 500 ppm.   
 
B- Calibration curves: each 500 ml stock solution of each pharmaceutical with a final 
concentration of 500 ppm prepared in (A) was used to prepare the following diluted solutions: 
1 ppm, 5 ppm, 10 ppm, 20 ppm, 50 ppm, and 100 ppm. Then, the absorption of each solution 
of each of the tested compounds was determined using UV-vis. 
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3.3.4.2 Batch adsorption studies   
Batch adsorption experiment was carried out for 100 ml solutions of 10 ppm, 50 ppm, 
100 ppm, 250 ppm, and 500 ppm, separately, as an initial concentration of the selected 
pharmaceutical. The Experiment was performed in 250 ml Erlenmeyer flasks containing 0.5 g 
micelle-clay complex or activated carbon (dosage 5g/L). The flasks were shaken in an electric 
shaker for two hours at room temperature, and then the content of the flask was centrifuged 
for 5 minutes and filtered using 0.45 μm syringes Millipore nylon filter. A kinetic study of the 
extent of adsorption was determined by conducting 100 ml solution of 50 ppm for each 
selected pharmaceutical, separately, in 250 ml Erlenmeyer flask containing 0.5 g of micelle-
clay complex or activated carbon then samples were taking as a function of time, centrifuged 
all samples for 5 minutes and filtered using 0.45 μm syringe Millipore nylon filter, and 
finally, measuring the concentration of the solution vs. time. 
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Chapter Four 
Results and Discussion 
 
4.1. Stability studies of selected pharmaceuticals. 
 
4.1.1. Stability of paracetamol and p-aminophenol 
 
4.1.1.1 Calibration Curve of paracetamol and p-aminophenol standard using HPLC 
method 
 
Calibration curve was obtained by plotting area under paracetamol peak versus 
paracetamol concentration in ppm (Table 4.1) and area under p-aminophenol peak versus p-
aminophenol concentration in ppm (Table 4.2). The method gave a linear relationship within 
the concentration range of 0.5–50 ppm with correlation coefficient r2 = 0.999 and r2 = 0.997, 
respectively, as shown in Figures 4.1 &4.2. 
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Table 4.1: Area under peak of paracetamol standard at different concentrations. 
Paracetamol Concentration (ppm) Peak Area  
0.5 19653 
1 57440 
5 240765 
10 449423 
50 2232590 
 
 
 
Figure 4.1: Calibration curve of paracetamol using HPLC method. 
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Table 4.2: Area under peak of p-aminophenol standard concentration. 
p-Aminophenol Concentration (ppm) Peak Area  
0.5 0 
1 471 
5 2353 
10 3260 
50 15634 
 
 
Figure 4.2: Calibration curve of p-aminophenol using HPLC method. 
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4.1.1.2 Stability of Paracetamol in fresh water. 
As mentioned in the introduction section, aqueous solution of paracetamol is quite 
stable at room temperature. The half-life of paracetamol solutions (pH 6) lasts over 20 years, 
however upon heating, acidic and basic conditions its stability decreases and it degrades to 
furnish p-aminophenol and acetic acid (Nelson et al., 2006). This hydrolysis reaction was 
found to be carried out by enzymatic cleavage or by microwave assisted alkaline hydrolysis of 
amide bond (Figure 4.5).  
 
Stability study of paracetamol in fresh water demonstrated that paracetamol was 
completely stable after incubation for more than one month due to high energy needed to 
overcome the barrier for the cleavage of its amide bond.  
 
HPLC monitoring results of paracetamol stability in fresh water gives the same 
retention time (3.9 min) belongs to paracetamol standard after 30 days incubation, as shown 
in (Figures 4.3 & 4.4). 
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Figure 4.3: Chromatogram showing paracetamol in fresh water after 2 days incubation at 
25
o
C. 
 
 
Figure 4.4: Chromatogram showing paracetamol in fresh water after 30 days incubation at 25 
o
C. 
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4.1.1.3 Stability of Paracetamol & p-aminophenol in activated sludge. 
HPLC monitoring results of Al-Quds University sludge solutions containing 
paracetamol revealed a gradual degradation of paracetamol to p-aminophenol and acetate 
(Figure 4.5). 
 
Figure 4.5: Schematic pathway for the degradation of paracetamol in Al-Quds sludge. 
The degradation was demonstrated by a disappearance of a peak characterized as the 
reactant (paracetamol) at a retention time of 3.9 minutes and a gradual appearance of a new 
peak at a retention time of 1.9 minutes characterized as a product (p-aminophenol). Figures 
4.6 and 4.7 illustrate a progress of paracetamol degradation as monitored by HPLC.  
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Figure 4.6: Chromatogram showing the hydrolysis of paracetamol after 2 days in presence of 
activated sludge at 25 
o
C. 
 
Figure 4.7: Chromatogram showing the hydrolysis of paracetamol after 7 days in presence of 
activated sludge at 25 
o
C. 
 
Characterization of the product, p-aminophenol was confirmed by injecting a mixture 
standard solution of paracetamol and p-aminophenol to HPLC that gave paracetamol peak at a 
retention time of 3.9 minutes and p-aminophenol peak at a retention time of 1.9 minutes 
(Figure 4.8).  
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Figure 4.8: Chromatogram showing separation of a mixture paracetamol and p-aminophenol. 
 
 
 
The HPLC kinetic data (Tables 4.3 and 4.4) obtained after one week monitoring was 
examined for linear correlation (Figures 4.9 and 4.10). A linear correlation was obtained when 
ln[paracetamol] and ln[p-aminophenol] was plotted against time with a correlation coefficient 
R
2
 = 0.9827, R
2
 = 0.9908, respectively . The pseudo first order reaction rate constants were 
found to be 2.17×10
-9
 M.s
-1
 and 8.64×10
-9
 M.s
-1
, respectively. 
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Table 4.3: Kinetic data for molar paracetamol concentration versus time at 25 
o
C. 
 
Ln[Paracetamol] M Time (hrs) 
-7.11356425 0 
-7.17295734 12 
-7.48992918 24 
-7.69084529 48 
-7.75383443 72 
-8.26910854 120 
-8.7748446 168 
 
 
 
Figure 4.9: First order kinetic plot for the biodegradation of paracetamol in Al-Quds 
activated sludge at 25 
0
C. 
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Table 4.4: Kinetic data for molar p-aminophenol concentration versus time at 25 
o
C. 
ln[p-aminophenol] M Time (hrs) 
-6.76534 0 
-7.25666 24 
-8.24042 72 
-9.24073 96 
-9.96466 120 
-10.4217 144 
-11.2532 168 
 
 
 
Figure 4.10: First order kinetic plot for the biodegradation of p-aminophenol in Al-Quds 
activated sludge at 25 
0
C.  
 
The degradation of paracetamol in Al-Quds University sludge might be due to the 
presence of variety of enzymes, bacteria, heavy metals, and etc. which have the potential to 
play a role in catalysis of the breakdown of paracetamol amide bond.  
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4.1.1.4 Biodegradation of Paracetamol and p-aminophenol in sterile peptone water 
contains Pseudomonas aeruginosa. 
 
Pseudomonas aeruginosa was sub-cultured from the bacteria characterized in the 
sludge of AQ-WWTP in sterile peptone water under complete sterile technique. The 
inoculated flask was incubated at 37 ºC for two hours to activate the growth of the bacteria, 
and then was transferred to a shaker. 200 mg paracetamol were added to the bacterial 
suspension having 0.5 optical densities. Paracetamol was extracted from the biological 
degradation reactor after 1, 2, 4, 7, 10 and 14 days. The extraction was performed using 
chloroform, and then liquid chromatography was performed to determine the concentrations 
of resulting metabolites. 
 
As deduced by HPLC determinations paracetamol was degraded within 14 days. 
During paracetamol degradation, two new metabolites were detected and tentatively identified 
by means of LC-MS and NMR (Figure 4.5). While the first metabolite reached its maximum 
around seven days, the second one increased until the end of the experiment (14 days) (Figure 
4.11).  
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Table 4.5: Kinetic biodegradation data of paracetamol and p-aminophenol versus time. The 
concentration values are repeated as a value of ± SD, SD: standard deviation of three 
replicates. 
 
Paracetamol p-Aminophenol 
Time (Days) Conc. (ppm) AV SD Conc.(ppm) AV SD 
0.0 100.03 2.42 0 
 0.5 99.54 5.94 0 
 1.0 84.45 4.73 3.17 2.92 
2.0 64.59 4.77 14.29 3.26 
3.0 50.93 2.26 35.06 2.72 
5.0 23.01 0.79 59.81 2.09 
7.0 14.38 0.38 62.85 1.76 
8.0 10.01 0.19 58.56 1.56 
11.0 2.90 0.17 42.09 0.71 
12.0 2.38 0.07 36.63 0.92 
14.0 1.63 0.29 29.67 1.11 
 
 
Figure 4.11: Biodegradation curve for paracetamol (white points ◊) 100 ppm initial 
paracetamol concentration, and p-aminophenol (Red points □) within 14 Days incubation at 
25
o
C. by pseudomonas aeruginosa. Data represent of average of triplicate measurements. 
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Metabolite 1 was characterized as p-aminophenol and the second metabolite was 
identified as hydroquinone. Metabolite 2 remained stable throughout the experimental period 
of 14 days. Transformation of paracetamol via metabolite 1 to metabolite 2 was confirmed by 
running a second set of experiments by which a standard solution of p-aminophenol was 
incubated with Pseudomonas aeruginosa in the same manner and conditions as described for 
paracetamol. HPLC monitoring demonstrated that p-aminophenol underwent degradation to 
hydroquinone (Figure 4.5). A complete biodegradation was achieved after 14 days of 
incubation with the bacteria.  
 
It is indicated that the identification of metabolites 1 and 2 was confirmed by injecting 
authentic samples of p-aminophenol and hydroquinone that gave identical peaks to the two 
metabolites, respectively.  
 
4.1.1.5 Variation of paracetamol concentration effect on biodegradation rate constant 
 
Different paracetamol concentrations in a sterile peptone water with Pseudomonas 
aeruginosa under complete sterile technique incubated with Pseudomonas aeruginosa in the 
same manner and conditions as described above. Paracetamol was extracted from the 
biological degradation reactor after 1 day, 2, 4, 7, 10 and 14 days. The extraction was 
performed using chloroform, and then liquid chromatography was performed to determine the 
degradation of paracetamol. 
 
The HPLC kinetic data (Table 4.6) obtained after one week monitoring was examined 
for linear correlation (Figure 4.12). A linear correlation was obtained when ln[paracetamol] 
was plotted against time with a correlation coefficient R
2
 = 0.994, R
2
 = 0.972 and R
2
 = 0.981 
respectively. The pseudo first order reaction rate constant was found to be 2.39×10
-9
 M.s
-1
, 
4.91×10
-9
 M.s
-1
 and 5.71×10
-9
 M.s
-1
, respectively. 
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Table 4.6: Kinetic data of different molar paracetamol concentration versus time at 25
o
C. 
 
100 ppm paracetamol 250 ppm paracetamol 500 ppm paracetamol 
Time (hrs) ln[paracetamol]M ln[paracetamol]M ln[paracetamol]M 
0 -7.32 -6.34 -5.68 
12 -7.33 -6.35 -5.68 
24 -7.49 -6.59 -5.82 
48 -7.76 -6.79 -5.91 
72 -7.99 -7.38 -5.97 
120 -8.79 -8.18 -6.25 
168 -9.26 -8.99 -6.81 
192 -9.62 -9.21 -7.09 
264 -10.86 -10.74 -7.31 
288 -11.06 -11.97 -7.49 
336 -11.44 -12.50 -7.71 
 
 
Figure 4.12: Variation the biodegradation rate of paracetamol with different concentration. 
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4.1.2 Stability of Benzamide 
 
4.1.2.1 Calibration Curve of Benzamide standard using HPLC method 
 
Calibration curve was obtained by plotting the area under benzamide peak versus 
benzamide concentration in ppm (Table 4.7). The plot gave a linear relation within the 
concentration range 10 – 200 ppm with correlation coefficient R2 = 0.999, as shown in Figure 
4.13. 
 
Table 4.7: Area under the peak of standard benzamide concentration. 
Benzamide Concentration (ppm) Peak Area  
0 0 
10 465001 
50 2437076 
100 4718702 
200 9505047 
 
 
Figure 4.13: Calibration curve of benzamide using HPLC method. 
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4.1.2.2 Stability of Benzamide in fresh water. 
 
In this experiment, as in paracetamol, benzamide was stable in aqueous media, where 
monitoring by HPLC showed the benzamide peak at a retention time 3.3 min after one day 
and 7 days incubation without being changed (Figures 4.14 and 4.15). 
 
 
Figure 4.14: Chromatogram showing a stability of benzamide in fresh water after 2 days 
incubation at 25 
o
C. 
 
Figure 4.15: Chromatogram showing a stability of benzamide in fresh water after 7 days 
incubation at 25 
o
C. 
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4.1.2.3 Stability of Benzamide in activated sludge 
 
Benzamide was revealed a gradual degradation to benzoic acid (Figure 4.16) within 
six days incubation at 25
o
C in activated sludge. The degradation was demonstrated by a 
disappearance of a peak characterized as the reactant (benzamide) at a retention time of 3.3 
minutes and a gradual appearance of a new peak at a retention time of 4.6 minutes 
characterized as benzoic acid, degradation product (Figure 4.19). Figures 4.17 and 4.18 
illustrate a progress of benzamide degradation as monitored by HPLC.  
 
NH2
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H+, H2O, heat
or enzyme
OH
O
 
Figure 4.16: Schematic pathway for a degradation of benzamide in Al-Quds sludge and by 
Pseudomonas aeruginosa bacteria.  
 
 
Figure 4.17: Chromatogram showing a hydrolysis of benzamide in activated sludge after 2 
days in presence of activated sludge at 25
o
C. 
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Figure 4.18: Chromatogram showing a hydrolysis of benzamide in activated sludge after 6 
days in presence of activated sludge at 25
o
C. 
 
 
Figure 4.19: Chromatogram showing a benzoic acid standard. 
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4.1.2.4 Biodegradation of Benzamide in sterile peptone water contains Pseudomonas 
aeruginosa. 
 
Pseudomonas aeruginosa was sub-cultured from the bacteria characterized in the 
sludge of AQU-WWTP in sterile peptone water under complete sterile technique. The 
inoculated flask was incubated at 37 ºC for two hours to activate the growth of the bacteria, 
and then was transferred to a shaker. 100 mg benzamide were added to the bacterial 
suspension having 0.5 optical densities. The product (metabolite) was extracted from the 
biological degradation reactor after 1, 2, 3, 4, 5, 6 and 7 days. The extraction was performed 
using chloroform, and then liquid chromatography was performed to determine the 
concentrations of resulting metabolites. 
 
As deduced by HPLC determinations benzamide was degraded within 6 days (Figure 
4.21). During benzamide degradation, new metabolite was detected and tentatively identified 
by means of LC-MS and NMR as benzoic acid (Figure 4.16). The HPLC kinetic data (Table 
4.8) obtained after one week monitoring was examined for linear correlation (Figure 4.20). A 
linear correlation was obtained when ln[benzamide] was plotted against time with a 
correlation coefficient R
2
 = 0.938. The pseudo first order reaction rate constant was found to 
be 7.86×10
-9
 M.s
-1
. 
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Table 4.8: Kinetic data of molar benzamide concentration versus time at 25 
o
C. 
Time (hrs) ln [Benzamide] M 
0 -7.0884 
24 -7.10198 
48 -7.53037 
72 -8.71401 
96 -9.26353 
120 -10.48 
144 -11.8459 
 
 
Figure 4.20: First order kinetic plot for the biodegradation of benzamide in pseudomonas 
aeruginosa at 25 
0
C. 
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Table 4.9: Kinetic data of benzamide biodegradation versus time at 25
o
C. 
Time (Days) Benzamide Concentration (ppm) AV ±SD 
0 101.11 5.92 
1 99.76 8.01 
2 64.99 5.69 
3 19.89 6.69 
4 11.49 2.39 
5 3.40 0.82 
6 0.89 0.73 
 
 
Figure 4.21: Benzamide concentration decay versus time when incubated with pseudomonas 
aeruginosa at 25 
0
C. Data represent of average of triplicate measurements. 
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4.2 Efficiency of AQU-WWTP for the removal of selected pharmaceuticals. 
 
4.2.1 Removal of Paracetamol 
4.2.1.1 Calibration curve of paracetamol standard using UV-spectrophotometer method 
 
Calibration curve was obtained by plotting absorbance of paracetamol versus 
paracetamol concentration in ppm at 245 nm wavelengths (Table 4.10). The method gave a 
linear correlation within the concentration range 0.1– 50 ppm with correlation coefficient r2 = 
0.996, as shown in Figure 4.22. 
Table 4.10: Standard of paracetamol concentration versus absorbance. 
Concentration (ppm) Absorbance 
0 0 
0.1 0.007 
0.5 0.021 
1 0.032 
5 0.154 
10 0.301 
50 2.158 
 
 
Figure 4.22: Calibration curve of paracetamol using UV-spectrophotometer method. 
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4.2.1.2 AQU-WWTP efficiency for paracetamol removal 
 
The efficiency of AQU-WWTP for paracetamol removal was studied. The result 
demonstrated that paracetamol was 46% removed at the hollow fiber membrane, while about 
84% of paracetamol was removed at the spiral wound membrane, (Table4.11). At the 
activated carbon adsorbent point of the wastewater treatment plant, 99% of paracetamol was 
removed. The results also indicated that a complete removal (100%) of paracetamol was 
achieved through the reverse osmosis membranes (RO). 
 
Table 4.11: Percentage removal of paracetamol after passing through the UF-HF, UF-SW, AC 
and RO of AQU-WWTP membranes. 
Parameter Paracetamol Concentration (ppm) % Removal 
Before addition (Blank) 0  
After addition (Inlet) 46.27 ± 1.64 
Ultra-Filtration-
Hollow Fiber  
Product  24.76 ± 2.97 46 
Brine 22.75 ± 1.79 
Ultra-Filtration-
Spiral Wound 
Product 7.61 ± 1.56 84 
Brine 14.26 ± 0.33 
Activated Carbon 0.15 ± 0.06 99 
Reverse 
Osmosis  
Product 0 100 
Brine 0.14 ± 0.11 
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4.2.2 Removal of P-aminophenol 
4.2.2.1 Calibration curve of p-aminophenol standard using UV-spectrophotometer 
method 
 
Calibration curve was obtained by plotting absorbance of p-aminophenol versus p-
aminophenol concentration in ppm at 245 nm wavelength (Table 4.12). The method gave a 
linear relation within the concentration in the range 0 – 50 ppm with correlation coefficient r2 
= 0.999, as shown in Figure 4.23. 
 
Table 4.12: Standard p-aminophenol concentration versus absorbance 
Concentration (ppm) Absorbance 
0 0 
0.1 0.001 
0.5 0.021 
1 0.072 
5 0.254 
10 0.381 
50 2.158 
 
 
Figure 4.23: Calibration curve of p-aminophenol using UV-spectrophotometer method. 
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4.2.2.2 AQU-WWTP efficiency for p-aminophenol removal 
 
The efficiency of AQU-WWTP for p-aminophenol removal was studied. The results 
demonstrated that p-aminophenol was 43% removed at the hollow fiber membrane, while 
about 80% of p-aminophenol was removed at the spiral wound membrane, (Table4.13). The 
results also indicated that a complete removal (100%) of p-aminophenol was achieved after 
passing through the activated carbon and reverse osmosis membranes (RO), respectively. 
 
Table 4.13: Percentage removal of p-aminophenol after passing through the UF-HF, UF-SW, 
AC and RO of AQU-WWTP membranes. 
Parameter p-aminophenol Concentration (ppm) % Removal 
Before addition (Blank) 0  
After addition (Inlet) 49.53 ± 1.07  
Ultra-Filtration-
Hollow Fiber  
Product  28.15 ± 0.72 43 
Brine 22.75 ± 1.79 
Ultra-Filtration-
Spiral Wound 
Product 9.96 ± 0.65 80 
Brine 13.35 ± 0.46 
Activated Carbon 0 100 
Reverse 
Osmosis  
Product 0 100 
Brine 0 
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4.2.3 Removal of Benzamide 
4.2.3.1 Calibration curve of benzamide standard using UV-spectrophotometer method 
 
Calibration curve was obtained by plotting absorbance of benzamide versus 
benzamide concentration in ppm at 226 nm wavelength (Table 4.14). The method gave a 
linear relation within the concentration range 0.1 – 50 ppm with correlation coefficient r2 = 
0.998, as shown in Figure4.24. 
 
Table 4.14: Standard benzamide concentration versus absorbance 
Concentration (ppm) Absorbance 
0 0 
0.1 0.012 
0.5 0.031 
1 0.053 
5 0.159 
10 0.226 
50 1.315 
 
 
Figure 4.24: Calibration curve of benzamide using UV-spectrophotometer method. 
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4.2.3.2 AQU-WWTP efficiency for benzamide removal 
 
The efficiency of AQU-WWTP for benzamide removal was studied. The result 
demonstrated that benzamide was 40% removed at the hollow fiber membrane, while about 
86% of benzamide was removed at the spiral wound membrane, (Table4.15). The results also 
indicated that a complete removal (100%) of benzamide was achieved after passing through 
the activated carbon and reverse osmosis membranes (RO), respectively. 
 
Table 4.15: Percentage removal of benzamide after passing through the UF-HF, UF-SW, AC 
and RO stages of AQU-WWTP. 
parameter Benzamide Concentration (ppm) % Removal 
Before addition (Blank) 0  
After addition (Inlet) 34.70 ± 0.82  
Ultra-Filtration-
Hollow Fiber  
Product  20.96 ± 188 40 
Brine 13.49 ± 1.49 
Ultra-Filtration-
Spiral Wound 
Product 4.92 ± 0.96 86 
Brine 10.12 ± 1.21 
Activated Carbon 0 100 
Reverse 
Osmosis  
Product 0 100 
Brine 0 
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4.2.4 Removal of Bezafibrate 
4.2.4.1 Calibration curve of bezafibrate standard using UV-spectrophotometer method 
 
Calibration curve was obtained by plotting the absorbance of bezafibrate versus its 
concentration in ppm at 231 nm wavelength (Table 4.16). The method gave a linear relation 
within the concentration range of 0.1 – 10 ppm with correlation coefficient R2 = 0.998, as 
shown in Figure 4.25. 
 
Table 4.16: Standard bezafibrate concentration versus absorbance 
Concentration (ppm) Absorbance 
0 0 
0.1 0.019 
0.5 0.047 
1 0.126 
5 0.431 
10 0.852 
 
 
Figure 4.25: Calibration curve of bezafibrate using UV-spectrophotometer method. 
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4.2.4.2 AQU-WWTP efficiency for bezafibrate removal 
 
The efficiency of AQU-WWTP for bezafibrate removal was studied. The result 
demonstrated that bezafibrate was 52% removed at the hollow fiber membrane, while about 
95% of bezafibrate was removed at the spiral wound membrane (Table4.17). The results also 
indicated that a complete removal (100%) of bezafibrate was achieved after passing the 
pharmaceutical through the activated carbon and reverse osmosis membranes (RO), 
respectively. 
 
Table 4.17: Percentage removal of bezafibrate after passing through the UF-HF, UF-SW, AC 
and RO of AQU-WWTP membrane. 
Parameter Bezafibrate Concentration (ppm) % Removal 
Before addition (Blank) 0  
After addition (Inlet) 29.19 ± 1.05  
Ultra-Filtration-
Hollow Fiber  
Product  14.09 ± 0.80 52 
Brine 11.26 ± 0.55 
Ultra-Filtration-
Spiral Wound 
Product  1.59 ± 0.69 95 
Brine 8.59 ± 1.49 
Activated Carbon 0 100 
Reverse Osmosis  Product 0 100 
Brine 0 
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4.2.5 Removal of Atenolol 
4.2.5.1 Calibration curve of atenolol standard using UV-spectrophotometer method 
Calibration curve was obtained by plotting the absorbance of atenolol versus its 
concentration in ppm at 273 nm wavelength (Table 4.18). The method gave a linear relation 
within the concentration range 0.1 – 50 ppm with a correlation coefficient of r2 = 0.999, as 
shown in Figure 4.26. 
 
Table 4.18: Standard atenolol concentration versos absorbance 
Concentration (ppm) Absorbance 
0.1 0.009 
0.5 0.026 
1 0.052 
5 0.15 
10 0.341 
50 1.632 
 
 
 
Figure 4.26: Calibration curve of atenolol using UV-spectrophotometer method. 
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4.2.5.2 AQU-WWTP efficiency for atenolol removal 
 
The efficiency of AQU-WWTP for atenolol removal was studied. The results 
demonstrated that atenolol was 44% removed at the hollow fiber membrane, while about 96% 
of atenolol was removed at the spiral wound membrane (Table 4.19). The results also 
indicated that a complete removal (100%) of atenolol was achieved after passing through the 
activated carbon and reverse osmosis membranes (RO), respectively. 
 
Table 4.19: Percentage removal of atenolol after passing through the UF-HF, UF-SW, AC and 
RO of AQU-WWTP membranes. 
Parameter Atenolol Concentration (ppm) % Removal 
Before addition (Blank) 0  
After addition (Inlet) 31.39 ± 0.53  
Ultra-Filtration-
Hollow Fiber  
Product  17.53 ± 1.19 44 
Brine 11.33 ± 0.67 
Ultra-Filtration-
Spiral Wound 
Product 1.75 ± 0.96 96 
Brine 13.69 ± 1.79 
Activated Carbon  100 
Reverse Osmosis  Product  100 
Brine  
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4.3 Adsorption studies of selected pharmaceuticals into micelle-clay complex and 
activated carbon 
 
Herein, results for the removal of paracetamol and its metabolite, p-aminophenol in 
suspension by a micelle-clay complex in comparison with activated carbon are presented. The 
micelles of the organic cation octadecyltrimethylammonium (ODTMA) interact with 
negatively charged clay (montmorillonite) at optimal ratios (Polubesova 2005, 2006). The 
complex has a very large surface area per weight; it includes large hydrophobic parts and has 
an excess of a positive charge, about half of the exchange capacity of the clay. X-ray 
diffraction, electron microscopy and adsorption experiments indicated that the material 
characteristics of the micelle-clay complex are different from those of an organo-clay 
complex, which is formed by adsorption of the same organic cation as monomer (Mishael 
2002). The micelle-clay is ideally suited for the adsorption of anionic organic molecules e.g., 
herbicides (Polubesova 2005), humic acid, dissolved organic matter (DOM) (Radian 2011), 
certain antibiotics (Polubesova 2006, Karaman 2012), as well as certain inorganic anions, 
such as perchlorate (Nir 2015). Filters filled with a micelle-clay complex mixed with sand 
were employed to study the ability of the mixture adsorbents in removing a variety of 
pharmaceuticals (Karaman 2012, Awwad 2015). 
4.3.1 Adsorption of paracetamol & p-aminophenol 
 
4.3.1.1 Kinetic Adsorption. 
 
Figures 4.27 and 4.28 and Tables 4.21 and 4.22 demonstrate a decrease in paracetamol 
and p-aminophenol concentrations, respectively, with function of time using either micelle-
clay complex or activated carbon. This revealing that micelle-clay complex is efficient for 
paracetamol and p-aminophenol removal. 
 
 
 
 
 
 
61 
 
Table 4.20: Kinetic data for the removal of paracetamol into micelle-clay complex and 
activated carbon. 
Adsorbent Micelle-Clay Complex Activated Carbon 
Time (minutes) Concentration (ppm) Concentration (ppm) 
0 50.13 ± 1.20 50.29 ± 1.51 
2 23.85 ± 1.62 17.89 ± 2.63 
5 13.76 ± 1.95 8.15 ± 1.90 
10 8.59 ± 2.13 3.94 ± 2.16 
20 1.89 ± 1.03 1.49 ± 0.93 
30 1.66 ± 1.08 0.99 ± 0.08 
40 1.24 ± 1.11 0.67 ± 1.01 
60 0.71 ± 0.07 0.32 ± 0.07 
80 0.27 ± 0.03 0.16 ± 0.03 
100 0.32 ± 0.10 0.04 ± 0.03 
120 0.24 ± 0.14 0.02 ± 0.08 
 
 
Figure 4.27: Kinetic adsorption of paracetamol into the Micelle-Clay complex (♦) and 
activated carbon (■). Temp. = 25.0 oC, and adsorbent dosage = 5.0 g/L. 
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Table 4.21: Kinetic data for the removal of p-aminophenol into micelle-clay complex and 
activated carbon. 
Adsorbent  Micelle-Clay Complex Activated Carbon 
Time (min) Conc. (ppm) Conc. (ppm) 
0 51.73 ± 2.40 51.49± 2.50 
2 44.40± 1.83 42.79±3.83 
5 33.61± 2.42 29.26± 3.61 
10 11.17 ± 1.61 4.68± 2.90 
20 2.45 ± 1.04 1.66± 1.82 
30 1.87 ± 1.52 1.29± 1.20 
40 1.36 ± 0.85 1.03± 0.85 
60 1.33± 0.04 0.87± 0.30 
80 1.49± 0.18 0.59± 0.24 
100 1.43 ± 0.69 0.54± 0.93 
120 1.45 ± 0.57 0.38± 0.79 
 
 
Figure 4.28: Kinetic adsorption of p-aminophenol into the Micelle-Clay complex (♦) and 
activated carbon (■). Temp. = 25.0 oC, and adsorbent dosage = 5.0 g/L. 
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4.3.1.2 Adsorption Isotherm 
 
The adsorption of selected pharmaceuticals onto a clay micelles complex and charcoal 
was analyzed by the Langmuir isotherm equation as shown below: 
 
Ce
Qe
=
1
K∗Qmax
+
Ce
Qmax
                             (1) 
 
Where: 
Ce: equilibrium concentration of (solute, e.g., paracetamol) (ppm). 
Qe: equilibrium mass of adsorbed selected pharmaceuticals per gram of absorbent (mg/g). 
K: Langmuir affinity constant (L/mg). 
Qmax: Maximum amount of solute adsorbed per gram of micelle- clay complex, or charcoal 
(mg/g). 
 
Adsorption of paracetamol is well described by Langmuir adsorption isotherm as 
shown by the plot of Ce\Qe versus Ce (Table 4.23, Figure 4.29). The correlation coefficient 
values (R
2
) obtained by the two adsorbents were summarized in Table 4.22.The calculated 
Qmax and K values for the removal of the paracetamol (Table 4.22) are 47.17 ± 6.21 mg/ g and 
0.054 ±0.007 L/mg, respectively using micelle-clay complex. The corresponding values in the 
case of activated carbon are Qmax =46.73 ± 4.05 mg/g and K= 0.391 ± 0.020 L/mg, this 
indicates that no significant difference between the activated carbon and micelle-clay 
complex, the affinity coefficient, k, for the activated carbon was larger than that for micelle-
clay complex. 
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Table 4.22: Langmuir constant (Qmax& K) and correlation coefficient for adsorption isotherm 
of paracetamol into micelle-clay complex and activated carbon. 
 Adsorbent  Qmax (mg/g) K  (L/mg) R
2
 
Paracetamol Micelle-Clay Complex 47.17 ± 6.21 0.05 ±0.02 0.974 
Activated Carbon 46.73 ± 4.05 0.39 ± 0.20 0.965 
 
Table 4.23: Langmuir isotherm parameter for adsorption of adsorbate paracetamol into 
micelle-clay complex and activated carbon as adsorbent. 
Micelle-Clay Complex Activated Carbon 
Ce (ppm) Ce/Qe (g/L) Ce (ppm) Ce/Qe (g/L) 
0.29 0.30 -0.004 -0.005 
1.29 0.26 0.02 0.004 
6.02 0.64 0.73 0.07 
24.08 1.07 9.42 0.39 
95.69 2.37 45.30 0.99 
 
 
Figure 4.29: Plot of Langmuir isotherm for the adsorption of paracetamol into the micelle-clay 
complex (♦) and activated carbon (■). Contact time = 2 h, Temp. = 25.0 ∘C, and adsorbent 
dosage = 5.0 g/L. 
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Adsorption of p-aminophenol is well described by Langmuir adsorption isotherm as 
shown by the plot of Ce\Qe versus Ce (Table 4.25 and Figure 4.30). The correlation coefficient 
values (R
2
) obtained by the two adsorbents were summarized in Table 4.24. The Qmax and K 
values determined for the removal of the p-aminophenol (Table 4.24) are 44.25 ± 5.28mg/g 
and 0.033 ±0.019 L/mg, respectively using micelle-clay complex. The corresponding values 
in the case of activated carbon are Qmax = 50.00 ± 7.32 mg/g and K= 0.033 ± 0.002 L/mg. The 
Qmax for micelle-clay complex was higher than that for the activated carbon, the affinity 
coefficient, k, for both micelle-clay complex and activated carbon was equal. 
 
 
Table 4.24: Langmuir constant and correlation coefficient for adsorption isotherm of p-
aminophenol into micelle-clay complex and activated carbon. 
 Adsorbent  Qmax (mg/g) K  (L/mg) R
2
 
P-aminophenol Micelle-Clay Complex 44.25 ± 5.28 0.033 ±0.019 0.945 
Activated Carbon 50.00 ± 7.32 0.033 ± 0.002 0.962 
 
Table 4.25: Langmuir isotherm parameter for adsorption of adsorbate p-aminophenol into 
micelle-clay complex and activated carbon as adsorbent. 
Micelle-Clay Complex Activated Carbon 
Ce (ppm) Ce/Qe (g/L) Ce (ppm) Ce/Qe (g/L) 
0 0 0 0 
4.05 0.88 1.75 0.36 
8.12 0.88 6.33 0.68 
33.70 1.56 28.17 1.27 
134.60 3.68 117.58 3.07 
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Figure 4.30: Plot of Langmuir isotherm for the adsorption of p-aminophenol into the micelle-
clay complex (♦) and activated carbon (■). Contact time = 2 h, Temp. = 25.0 oC, and adsorbent 
dosage = 5.0 g/L. 
 
The adsorption of paracetamol and p-aminophenol were analyzed as well by Freundlich 
isotherm equation: 
log𝑄𝑒 = log 𝑘 +
1
𝑛
𝑙𝑜𝑔𝐶𝑒                       (2) 
Ce: equilibrium concentration of adsorbate (ppm). 
Qe: equilibrium mass of adsorbed selected pharmaceuticals per gram of absorbent (mg/g). 
K and n: Freundlich parameter constant. 
 
Adsorption of paracetamol is well described by plot log (Qe) versus log (Ce) (Table 
4.27). The correlation coefficient values (R
2
) obtained by the two adsorbents are summarized 
in Table 4.26.The fitted equilibrium data in Freundlich isotherm expression is shown in 
Figure 4.31. It is observed that the equilibrium data fitted very well in Freundlich expression 
with very high correlation coefficients, thus confirming the applicability of the isotherm. For 
using activated carbon a larger value of k indicates good adsorption efficiency, while a larger 
value of 1/n for micelle-clay complex indicates a larger change in effectiveness over different 
equilibrium concentrations. 
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Table 4.26: Freundlich constant and correlation coefficient for the adsorption isotherm of 
paracetamol into micelle-clay complex and activated carbon 
 Adsorbent  1/n K   R
2
 
Paracetamol Micelle-Clay Complex 0.62 ± 0.47 2.87 ± 1.09 0.965 
Activated Carbon 0.28 ± 0.02 13.49 ± 2.96 0.968 
 
Table 4.27: Freundlich isotherm parameter for adsorption of adsorbate paracetamol into 
micelle-clay complex and activated carbon as adsorbent. 
Micelle-Clay Complex Activated Carbon 
log (Ce) log (Qe) log (Ce) log (Qe) 
-0.53 -0.01 
  0.11 0.69 -1.73 0.69 
0.78 0.97 -0.13 0.99 
1.38 1.35 0.97 1.38 
1.98 1.61 1.66 1.66 
 
 
Figure4.31: Plot of Freundlich isotherm for the adsorption of paracetamol into the Micelle-
Clay complex (♦) and activated carbon (■). Contact time = 2 h, Temp. = 25.0oC, and 
adsorbent dosage = 5.0 g/L. 
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Adsorption of p-aminophenol is well described by plot log (Qe) versus log (Ce), (Table 
4.29). The correlation coefficient values (R
2
) obtained by the two adsorbents are summarized 
in Table4.28.The fitted equilibrium data in Freundlich isotherm expression is shown in 
Figure4.32. It is observed that the equilibrium data fitted very well in Freundlich expression 
with high correlation coefficients, thus confirming the applicability of the isotherm. The 
values of k and 1/n indicate that no significant different for both micelle-clay complex and 
activated carbon. 
 
Table 4.28: Summarized the Freundlich constant and correlation coefficient for adsorption 
isotherm of p-aminophenol into micelle-clay complex and activated carbon.  
 Adsorbent  1/n K   R
2
 
p-aminophenol Micelle-Clay Complex 0.67 ± 0.38 1.77 ± 0.83 0.948 
Activated Carbon 0.69 ± 0.20 1.95 ± 0.98 0.984 
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Table 4.29: Freundlich isotherm parameter for adsorption of adsorbate p-aminophenol into 
micelle-clay complex and activated carbon as adsorbent. 
Micelle-Clay Complex Activated Carbon 
log (Ce) log (Qe) log (Ce) log (Qe) 
-0.15 -0.03 -0.34 -0.02 
0.39 0.68 0.51 0.67 
0.95 0.96 0.85 0.97 
1.53 1.33 1.46 1.34 
2.13 1.56 2.02 1.59 
 
 
Figure 4.32: Plot of Freundlich isotherm for the adsorption of p-aminophenol into the 
Micelle-Clay complex (♦) and activated carbon (■). Contact time = 2 h, Temp. = 25.0 oC, and 
adsorbent dosage = 5.0 g/L. 
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4.3.2 Adsorption of benzamide 
 
4.3.2.1 Kinetic Adsorption. 
 
Figure 4.33shows a decrease in benzamide concentration versus time when adsorbed 
by either micelle-clay complex or activated carbon. This reveals that micelle-clay complex 
and activated carbon are efficient for benzamide removal. 
 
Table 4.30: Kinetic data for the removal of benzamide into micelle-clay complex and 
activated carbon. 
Adsorbent Micelle-Clay Complex Activated Carbon 
Time (minutes) Concentration (ppm) Concentration (ppm) 
0 51.79 ± 2.71 49.72 ± 3.68 
1 38.57 ± 3.11 35.45 ± 2.13 
5 26.29 ± 2.83 20.37 ± 3.90 
10 10.87 ± 1.97 5.87 ± 2.77 
20 3.14 ± 1.02 2.33 ± 0.28 
40 3.26 ± 1.42 1.68 ± 0.54 
60 2.03 ± 1.69 1.10 ± 0.96 
80 0.99 ± 0.14 0.45 ± 0.42 
100 0.87 ± 0.51 0.57 ± 0.16 
120 1.07 ± 0.09 0.49 ± 0.95 
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Figure 4.33: Kinetic adsorption of benzamide into the micelle-clay complex (♦) and activated 
carbon (■). Temp. = 25.0 oC, and adsorbent dosage = 5.0 g/L. 
 
4.3.2.2 Adsorption Isotherm 
 
Adsorption of benzamide was described by Langmuir adsorption isotherm as shown 
by the plot of Ce\Qe versus Ce (Table 4.32 and Figure 4.34). The correlation coefficient values 
(R
2
) obtained by the two adsorbents are summarized in Table4.31.The Qmax and K values 
determined for the removal of the benzamide using micelle-clay complex (Table 4.31) are 
87.72 ± 10.60 mg/g and 0.04 ± 0.01 L/mg, respectively. The corresponding values in the case 
of activated carbon are Qmax = 93.46 ± 8.04 mg/g and K= 0.46 ± 0.07 L/mg. The Qmax for 
micelle-clay complex was smaller than that for the activated carbon, the affinity coefficient, k, 
for activated carbon was 11 fold larger than micelle-clay complex. 
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Table 4.31: Langmuir constant and correlation coefficient for the adsorption isotherm of 
benzamide into micelle-clay complex and activated carbon. 
 Adsorbent  Qmax (mg/g) K  (L/mg) R
2
 
Benzamide Micelle-Clay Complex 87.72 ± 10.60 0.04 ±0.01 0.983 
Activated Carbon 93.46 ± 8.04 0.46 ± 0.07 0.996 
 
Table 4.32: Langmuir isotherm parameter for adsorption of adsorbate benzamide into micelle-
clay complex and activated carbon as adsorbent. 
Micelle-Clay Complex Activated Carbon 
Ce (mg/L) Ce/Qe (g/L) Ce (mg/L) Ce/Qe (g/L) 
0.45 0.24 0.01 0.004 
2.79 0.29 0.23 0.02 
8.29 0.45 0.59 0.03 
36.28 0.85 4.65 0.09 
130.47 1.77 48.79 0.54 
 
 
Figure 4.34: Plot of Langmuir isotherm for the adsorption of benzamide into the micelle-clay 
complex (♦) and activated carbon (■). Contact time = 2 h, Temp. = 25.0 oC, and adsorbent 
dosage = 5.0 g/L. 
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Adsorption of benzamide was described by plot log (Qe) versus log (Ce) (Table 4.34). 
The correlation coefficient values (R
2
) obtained by the two adsorbents are summarized in 
Table4.33.The fitted equilibrium data in Freundlich isotherm expression is shown in Figure 
4.35. It is observed that the equilibrium data fitted very well in Freundlich expression with 
very high correlation coefficients, thus confirming the applicability of the isotherm. For using 
activated carbon a larger value of k indicates good adsorption efficiency, while a larger value 
of 1/n for micelle-clay complex indicates a larger change in effectiveness over different 
equilibrium concentrations. 
 
Table 4.33: Freundlich constant and correlation coefficient for adsorption isotherm of 
benzamide into micelle-clay complex and activated carbon. 
 Adsorbent  1/n K   R
2
 
Benzamide Micelle-Clay Complex 1.15 ± 0.88 43.21 ± 7.03 0.975 
Activated Carbon 0.64 ± 0.49 157.91 ± 14.51 0.891 
 
Table 4.34: Freundlich isotherm parameter for adsorption of adsorbate benzamide into micelle-
clay complex and activated carbon as adsorbent. 
Micelle-Clay Complex Activated Carbon 
log (Qe) log (Ce) log (Qe) log (Ce) 
0.28 -0.63 0.30 -2.32 
0.98 -0.53 0.99 -1.63 
1.26 -0.34 1.29 -1.53 
1.63 -0.07 1.69 -1.02 
1.87 0.25 1.96 -0.27 
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Figure 4.35: Plot of Freundlich isotherm for the adsorption of benzamide into the micelle-
clay complex (♦) and activated carbon (■). Contact time = 2 h, Temp. = 25.0 oC and adsorbent 
dosage = 5.0 g/L. 
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4.3.3 Adsorption of bezafibrate 
 
4.3.3.1 Kinetic adsorption. 
 
Figure 4.36 shows a decrease in bezafibrate concentration with time using either 
micelle-clay complex or activated carbon. This reveals that activated carbon and micelle-clay 
complex are efficient for bezafibrate removal. 
 
Table 4.35: Kinetic data for the removal of bezafibrate by micelle-clay complex and activated 
carbon. 
Adsorbent Micelle-Clay Complex Activated Carbon 
Time (minutes) Concentration (ppm) Concentration (ppm) 
0 47.26 ± 2.25 48.61 ± 4.01 
1 42.19 ± 3.07 38.03 ± 2.67 
2 40.34 ± 3.91 29.91 ± 5.01 
5 27.19 ± 2.14 17.81 ± 2.19 
10 16.22 ± 1.44 7.26 ± 2.02 
20 6.10 ± 0.79 3.79 ± 1.08 
40 3.24 ± 1.01 1.42 ± 2.31 
60 3.28 ± 0.97 1.58 ± 0.97 
80 2.10 ± 1.09 1.55 ± 0.48 
100 2.04 ±1.22 1.52 ± 1.9 
120 2.10 ± 1.04 1.55 ± 1.68 
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Figure 4.36: Kinetic adsorption of bezafibrate by the Micelle-Clay complex (♦) and activated 
carbon (■).Temp. = 25.0 oC, and adsorbent dosage = 5.0 g/L. 
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4.3.3.2 Adsorption Isotherm 
 
Adsorption of bezafibrate was described by Langmuir adsorption isotherm as shown 
by the plot of Ce\Qe versus Ce (Table 4.37 and Figure 4.37). The correlation coefficient values 
(R
2
) obtained by the two adsorbents are summarized in Table4.36.The Qmax and K values 
determined for the removal of the bezafibrate using Micelle-Clay complex (Table 4.36) 
are88.49 ± 6.23mg/g and0.03 ±0.01L/mg, respectively,. The corresponding values in the case 
of activated carbon are Qmax= 82.64 ± 9.97mg/g and K = 0.12 ± 0.01L/mg. The Qmax for 
micelle-clay complex was higher than that for the activated carbon, the affinity coefficient, K, 
for activated carbon was 3 fold higher than for micelle-clay complex. 
 
Table 4.36: Langmuir constant and correlation coefficient for adsorption isotherm of 
bezafibrate by micelle-clay complex and activated carbon. 
 Adsorbent  Qmax (mg/g) K  (L/mg) R
2
 
Bezafibrate Micelle-Clay Complex 88.49 ± 6.23 0.03 ± 0.01 0.991 
Activated Carbon 82.64 ± 9.97 0.12 ± 0.01 0.973 
 
Table 4.37: Langmuir isotherm parameter for adsorption of adsorbate bezafibrate into 
micelle-clay complex and activated carbon. 
Micelle-Clay Complex Activated Carbon 
Ce (mg/L) Ce/Qe (g/L) Ce (mg/L) Ce/Qe (g/L) 
0.60 0.32 0.10 0.05 
3.72 0.40 0.69 0.07 
6.95 0.37 1.89 0.09 
36.85 0.86 25.96 0.58 
134.12 1.83 105.79 1.34 
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Figure 4.37: Plot of Langmuir isotherm for the adsorption of bezafibrate into the micelle-clay 
complex (♦) and activated carbon (■). Contact time = 2 h, Temp. = 25.0 oC, and adsorbent 
dosage = 5.0 g/L. 
 
Adsorption of bezafibrate was described by plot log (Qe) versus log (Ce) (Table 4.39). 
The correlation coefficient values (R
2
) obtained by the two adsorbents are summarized in 
Table4.38. The fitted equilibrium data in Freundlich isotherm expression is shown in Figure 
4.38. It is observed that the equilibrium data fitted very well in Freundlich expression with 
very high correlation coefficients, thus confirming the applicability of the isotherm. For using 
activated carbon a larger value of K indicates good adsorption efficiency, while a larger value 
of 1/n for micelle-clay complex indicates a larger change in effectiveness over different 
equilibrium concentrations. 
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Table 4.38: Freundlich constant and correlation coefficient for adsorption isotherm of 
bezafibrate into micelle-clay complex and activated carbon. 
 Adsorbent  1/n K   R
2
 
Bezafibrate Micelle-Clay Complex 0.67 ± 0.07 3.49 ± 1.34 0.964 
Activated Carbon 0.50 ± 0.29 9.32 ± 1.91 0.947 
 
 
Table 4.39: Freundlich isotherm parameter for adsorption of bezafibrate into micelle-clay 
complex and activated carbon. 
Micelle-Clay Complex Activated Carbon 
log (Ce) log (Qe) log (Ce) log (Qe) 
-0.22 0.27 -0.99 0.29 
0.57 0.97 -0.16 0.99 
0.84 1.27 0.28 1.29 
1.57 1.63 1.41 1.65 
2.13 1.86 2.02 1.89 
 
 
Figure 4.38: Plot of Freundlich isotherm for the adsorption of bezafibrate into the micelle-
clay complex (♦) and activated carbon (■). Contact time = 2 h, Temp. = 25.0 oC and adsorbent 
dosage = 5.0 g/L. 
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4.3.4 Adsorption of Atenolol  
 
4.3.4.1 Kinetic adsorption. 
 
Figure 4.39 shows a decrease in atenolol concentration versus time using either 
micelle-clay complex or activated carbon. This reveals that both activate carbon and micelle-
clay complex are efficient for atenolol removal. 
 
Table 4.40: Kinetic data for the removal of atenolol into micelle-clay complex and activated 
carbon. 
Adsorbent Micelle-Clay Complex Activated Carbon 
Time (minutes) Concentration (ppm) Concentration (ppm) 
0 49.23 ± 0.93 48.92 ± 1.04 
1 47.84 ± 1.81 38.03 ± 2.94 
2 42.72 ± 2.75 29.91 ± 2.07 
5 36.73 ± 2.92 23.98 ± 3.78 
10 20.62 ± 1.91 13.43 ± 2.91 
20 9.82 ± 3.31 4.42 ± 2.55 
40 7.35 ± 2.01 2.35 ± 3.74 
60 3.12 ± 1.04 1.27 ± 0.92 
80 2.81 ± 0.93  0.62 ± 0.02 
100 2.69 ± 1.13 0.59 ± 0.93 
120 3.12 ± 2.05 0.71 ± 0.07 
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Figure 4.39: Kinetic adsorption of atenolol onto the micelle-clay complex (♦) and activated 
carbon (■). Temp. = 25.0 oC, and adsorbent dosage = 5.0 g/L. 
 
4.3.4.2 Adsorption Isotherm 
 
Adsorption of atenolol was described by Langmuir adsorption isotherm as shown by 
the plot of Ce\Qe versus Ce (Table 4.42 and Figure 4.40). The correlation coefficient values 
(R
2
) obtained by the two adsorbents are summarized in Table4.41.The Qmax and K values 
determined for the removal of the atenolol using micelle-clay complex(Table 4.41)are 91.74 ± 
5.91 mg/g and 0.01±0.02 L/mg, respectively. The corresponding values in the case of 
activated carbon are Qmax = 75.76 ± 8.53 mg/g and K = 0.05 ± 0.01 L/mg. The Qmax for 
micelle-Clay complex was higher than that for the activated carbon, the affinity coefficient, 
K, for activated carbon was 5 fold higher than for micelle-clay complex. 
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Table 4.41: Langmuir constant and correlation coefficient for adsorption isotherm of atenolol 
onto micelle-clay complex and activated carbon. 
 Adsorbent  Qmax (mg/g) K  (L/mg) R
2
 
Atenolol Micelle-Clay Complex 91.74 ± 5.91 0.01 ±0.02 0.971 
Activated Carbon 75.76 ± 8.53 0.05 ± 0.01 0.995 
 
Table 4.42: Langmuir isotherm parameter for adsorption of adsorbate atenolol onto micelle-
clay complex and activated carbon as adsorbent. 
Micelle-Clay Complex Activated Carbon 
Ce (mg/L) Ce/Qe (g/L) Ce (mg/L) Ce/Qe (g/L) 
2.34 1.53 0.38 0.19 
12.87 1.73 2.59 0.27 
30.44 2.19 8.16 0.44 
77.12 2.23 34.04 0.79 
224.27 4.07 160.81 2.37 
 
 
Figure 4.40: Plot of Langmuir isotherm for the adsorption of atenolol onto the micelle-clay 
complex (♦) and activated carbon (■). Contact time = 2 h, Temp. = 25.0 oC, and adsorbent 
dosage = 5.0 g/L. 
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Adsorption of atenolol is well described by plot log (Qe) versus log (Ce) (Table 4.44). 
The correlation coefficient values (R
2
) obtained by the two adsorbents are summarized in 
Table4.43. The fitted equilibrium data in Freundlich isotherm expression is shown in Figure 
4.41. It is observed that the equilibrium data fitted very well in Freundlich expression with 
very high correlation coefficients, thus confirming the applicability of the isotherm. For using 
activated carbon a larger value of K indicates good adsorption efficiency, while a larger value 
of 1/n for micelle-clay complex indicates a larger change in effectiveness over different 
equilibrium concentrations. 
 
Table 4.43: Freundlich constant and correlation coefficient for adsorption isotherm of 
atenolol into micelle-clay complex and activated carbon. 
 Adsorbent  1/n K   R
2
 
Atenolol Micelle-Clay Complex 0.80 ± 0.19 0.87 ± 0.14 0.987 
Activated Carbon 0.59 ± 0.02 4.47 ± 1.09 0.968 
 
 
Table 4.44: Freundlich isotherm parameter for adsorption of atenolol onto micelle-clay 
complex and activated carbon. 
Micelle-Clay Complex Activated Carbon 
log (Ce) log (Qe) log (Ce) log (Qe) 
0.37 0.18 -0.43 0.28 
1.11 0.87 0.41 0.98 
1.48 1.14 0.91 1.26 
1.89 1.54 1.53 1.64 
2.35 1.74 2.21 1.83 
 
 
 
84 
 
 
Figure 4.41: Plot of Freundlich isotherm for the adsorption of atenolol into the micelle-clay 
complex (♦) and activated carbon (■). Contact time = 2 h, Temp. = 25.0 oC and adsorbent 
dosage = 5.0 g/L. 
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Chapter Five 
Conclusions and Recommendations  
 
 
5.1 Conclusions 
 
The stability results for the selected pharmaceuticals (paracetamol, p-aminophenol and 
benzamide); in activated sludge wastewater and suspended pseudomonas aeruginosa (bacteria 
which was isolated from AQ-WWTP) demonstrate that the amide bond contained in these 
compounds is cleaved by enzymatic bacteria. The resulted metabolites were identify and 
characterized by 1H-NMR and LC-MS. 
 
Biodegradation of paracetamol revealed the formation of p-aminophenol (metabolite-
1) which underwent biodegradation to hydroquinone (metabolite-2). On the other hand, 
benzamide underwent biodegradation to benzoic acid as a final metabolite. 
 
The ultrafiltration (hollow fiber and spiral wound membranes) used for the removal of 
selected pharmaceuticals (paracetamol, p-aminophenol, benzamide, bezafibrate and atenolol), 
has shown a removal of 40 – 80%, whereas, the activated carbon and reverse osmosis 
membranes were very efficient in removing these pharmaceuticals (~ 99.9%). Hence, we 
conclude that an activated carbon filter can be efficient in removing these pharmaceuticals 
without the need of expensive methods such as a reverse osmosis membrane. 
 
The adsorption isotherms were found to fit Langmuir and Freundlich isotherms and 
the corresponding adsorption parameters were evaluated. The adsorption kinetics and 
parameters strongly suggest that integrating clay-micelle filters within Al-Quds wastewater 
treatment plant is a promising technology for an efficient removal of the studied 
pharmaceuticals (paracetamol, p-aminophenol, benzamide, bezafibrate and atenolol) and their 
degradation products. 
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5.2 Recommendations 
 
Of the most important recommendations that should be taken into account are the following: 
 
 Application of micelle clay complex filter in large scale waste water treatment plant. 
 Increasing the public awareness toward the effect of pharmaceutical disposal on 
environment. 
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, دساست ثباتٍت الادوٌت انتً تحتوي عهى سوابط امٍذٌت فً انحماة اننشطت
انكشبون اننشط ومشكب مٍسم انصهصال , كفائت تقنٍت الاغشٍت انمتقذمت
 انمعقذ فً اصانت هزه الادوٌت
 
  ابشاهٍم عهً ابشاهٍم عٍاد: إعذاد 
  الاستار انذكتوس سفٍق قشمان: إششاف 
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